Lymphoma, AIDS-Related
B-cell lymphoid tumors that occur in association with AIDS. Patients often present with an advanced stage of disease and highly malignant subtypes including BURKITT LYMPHOMA; IMMUNOBLASTIC LARGE-CELL LYMPHOMA; PRIMARY EFFUSION LYMPHOMA; and DIFFUSE, LARGE B-CELL, LYMPHOMA. The tumors are often disseminated in unusual extranodal sites and chromosomal abnormalities are frequently present. It is likely that polyclonal B-cell lymphoproliferation in AIDS is a complex result of EBV infection, HIV antigenic stimulation, and T-cell-dependent HIV activation.
Drugs by status
Phase 2 trials (19)
Phase 1 trials (13)
Organizations
Organization Involved with Phase 2 Indications (13)
- Roche
- The EMMES Corporation
- French National Agency for Research on AIDS and Viral Hepatitis
- National Cancer Institute (NCI)
- AIDS Malignancy Consortium
- Harvard University
- Loyola University
- McMaster University
- Southwest Oncology Group
- University of Southern California
- University of Toronto
- University of Texas at Houston
- Hopital A Beclere Clamart
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (1)